Fact CheckerSign in

NCT06150300Not yet recruiting

Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

STAPLE (Severe asThmA PuLmonary rEhab): Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

Source: ClinicalTrials.gov · Last updated 29 Nov 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a randomized control trial evaluating the effect of a novel mobile application-delivered pulmonary rehabilitation program in adult severe asthma patients. The intervention will include eight weeks of exercise videos that progress in difficulty, as well as asthma-specific educational content. The primary outcome measure is change in functional exercise capacity as measured by six-minute walk distance. Secondary outcome measures will include evaluation of overall feasibility, and change in CPET parameters such as VO2max. Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and PRAISE self-efficacy score will also be evaluated.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
34 (estimated)
First submitted
20 Nov 2023
Start date
1 Jan 2024
Primary completion date
31 Dec 2025
Lead sponsor
University of Saskatchewan
Diseases
Asthma
NCT number
NCT06150300

What you commit to

  • Study type: Interventional
  • Planned participants: 34
  • From 1 Jan 2024 to the primary completion date, 31 Dec 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Exclusion criteria include comorbid cardiopulmonary or musculoskeletal conditions that may impact exercise tolerance in accordance with the American Thoracic Society CPET guidelines

Who the study is looking for

  • Adults aged 18 years and older with a diagnosis of asthma by a respirologist. They must have severe disease defined by GINA severity classification. Participants must have access to a smartphone or internet browser to allow access to study content.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.